Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06465693 · ClinicalTrials.gov registry record · NA

Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus

A NA study of Type 2 Diabetes, sponsored by University of Minnesota.

Active
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06465693: Active NA study of Type 2 Diabetes, sponsored by University of Minnesota.

NCT06465693 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 8 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06465693, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Nutrition guidelines state that multiple eating patterns are effective for type 2 diabetes and that therapy should be individualized. Yet many nutrition plans fail to account for interpersonal variability in blood glucose response to meals. This diminishes the ability of dietary interventions to optimize glycemic control and may lessen patient satisfaction, self--efficacy, and adherence. Continuous glucose monitoring (CGM) can facilitate behavior change in type 2 diabetes and has been associated with improved outcomes in nutrition intervention studies; this literature is limited by small study sample sizes and heterogeneity of study design and outcomes, and more data are needed. CGM could be a powerful tool for adapting a nutrition plan based on blood glucose response at an individual level. This study will test the use of CGM to personalize nutrition therapy compared to nutrition therapy alone (without CGM) for participants with type 2 diabetes who are not meeting glycemic treatment goals.

Conditions Studied

Type 2 Diabetes

Interventions

  • DEVICE Unblinded CGM plus nutrition therapy
  • BEHAVIORAL Nutrition therapy only

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2024-05-01
Est. Completion 2026-07-01
Phase NA
University of Minnesota

966 total trials

What the registry record for NCT06465693 still lists

NCT06465693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Unblinded CGM plus nutrition therapy is the first listed.

NCT06465693 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06465693 about?

NCT06465693 is a clinical study titled "Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus". Nutrition guidelines state that multiple eating patterns are effective for type 2 diabetes and that therapy should be individualized. Yet many nutrition plans fail to account for interpersonal variability in blood glucose response to meals. This diminishes the ability of dietary interventions to opt...

What is the current status of trial NCT06465693?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2024-05-01. Estimated completion is 2026-07-01.

What conditions does trial NCT06465693 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT06465693?

The interventions under investigation include: Unblinded CGM plus nutrition therapy (DEVICE), Nutrition therapy only (BEHAVIORAL).

Who is sponsoring clinical trial NCT06465693?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06465693 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06465693's enrollment target sits among peer trials

8 325th of 327 higher than 3 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06465693, the US trial registry maintained by the National Library of Medicine. NCT06465693 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.